Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: iProceedings

Date Submitted: May 5, 2022
Date Accepted: Jun 8, 2022

The final, peer-reviewed published version of this preprint can be found here:

Evaluation of MyCOVIDRisk App Users: An Updated Risk Evaluation and Mitigation Tool for Public Use

Ranney M, Goldberg E, Ernst Z, Perera S, Haut A, Bingaman C

Evaluation of MyCOVIDRisk App Users: An Updated Risk Evaluation and Mitigation Tool for Public Use

iProc 2022;8(1):e39294

DOI: 10.2196/39294

PMID: 27991568

PMCID: 5171637

Evaluation of MyCOVIDRisk App Users: an updated risk evaluation and mitigation tool for public use

  • Megan Ranney; 
  • Elizabeth Goldberg; 
  • Zahrie Ernst; 
  • Sudheesha Perera; 
  • Arenal Haut; 
  • Charlotte Bingaman

ABSTRACT

Background:

The MyCOVIDRisk.App is a free, web-based tool for the public to quickly estimate likelihood of COVID-19 infection based on individual behavior, environmental factors, and local case counts. User input of activities and mitigation measures impact the modifiable risk estimates. Originally launched October 2020, an updated version was released in November 2021 to account for the transmission dynamics of delta and omicron variants and the protective effects of vaccination.

Objective:

This study aims to assess trends in (1) user characteristics, (2) projected risk level, and (3) mitigation measures selected by users since its inception.

Methods:

We tracked overall site usage with Google Analytics. To describe user inputs (preferred activities, gathering sizes, vaccination status, and other risk mitigation steps), we aggregated backend app data logging every run of the risk analysis algorithm. We calculated descriptive statistics.

Results:

As of March 1, 2022 the MyCOVIDRisk App has been used 1,339,940 times (1,231,546 times in v1, 108,394 times in v2). Multiple characteristics of activities changed across the two versions. For example, the top activity in v1 was “Visiting Friends House” (22.6%, n=146,399); versus “Family Dinner” in v2 (21.3%, n=19,724). In v1, only 0.7% of users who were originally “high risk”, and 10.8% of “moderate” risk, decreased their predicted risk to “low” using layered mitigation steps. In comparison, in v2, 24.4% of high and 24.8% of moderate risk activities were decreased to low risk. Self-reported mask use also changed across versions. In v1, 83.7% planned to wear a mask, versus only 68.8% in v2. Of those masking, more users reported use of N95s and surgical masks in v2 (50.5%) compared to v1 (18.1%). Vaccination status was not asked in v1. In v2, 97% (n=37,346) reported having received at least 1 dose of vaccine, and 81.7% had received 3 doses. Among those participating in indoor activities in v2, 75.7% (n=83,728) indicated that they were participating in indoor activities with people that had received at least 2 doses of Pfizer or Moderna or 1 dose of Johnson and Johnson vaccines.

Conclusions:

The MyCOVIDRisk App allows individuals to assess real-time risk of being infected by SARS-CoV-2. Using app-directed mitigation steps, users were able to reduce their predicted risk of COVID transmission during daily activities. Patterns of mask use and types of activities changed over time. In v2, users were more likely to report being vaccinated/boosted and wearing masks than national statistics suggest. Future iterations of the app should assess actual change in behavior, and should aim to reach those who are not currently vaccinated or masking.


 Citation

Please cite as:

Ranney M, Goldberg E, Ernst Z, Perera S, Haut A, Bingaman C

Evaluation of MyCOVIDRisk App Users: An Updated Risk Evaluation and Mitigation Tool for Public Use

iProc 2022;8(1):e39294

DOI: 10.2196/39294

PMID: 27991568

PMCID: 5171637

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.